Effects of κ‐opioid receptor stimulation in the heart and the involvement of protein kinase C
- 1 June 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 124 (3) , 600-606
- https://doi.org/10.1038/sj.bjp.0701857
Abstract
1. The role of protein kinase C (PKC) in mediating the action of kappa-receptor stimulation on intracellular Ca2+ and cyclic AMP production was determined by studying the effects of trans-(+/-)-3,4-dichloro-N-methyl-N-(2-[1-pyrrolidinyl] cyclohexyl) benzeneacetamide methanesulphonate (U50,488H), a selective kappa-receptor agonist, and phorbol 12-myristate 13-acetate (PMA), a PKC agonist, on the electrically-induced [Ca2+]i transient and forskolin-stimulated cyclic AMP accumulation in the presence and absence of a PKC antagonist, staurosporine or chelerythrine, in the single rat ventricular myocyte. 2. U50,488H at 2.5-40 microM decreased both the electrically-induced [Ca2+]i transient and forskolin-stimulated cyclic AMP accumulation dose-dependently, effects which PMA mimicked. The effects of the kappa-agonist, that were blocked by a selective kappa-antagonist, nor-binaltorphimine, were significantly antagonized by the PKC antagonists, staurosporine and/or chelerythrine. The results indicate that PKC mediates the actions of kappa-receptor stimulation. 3. To determine whether the action of PKC was at the sarcoplasmic reticulum (SR) or not, the [Ca2+]i transient induced by caffeine, that depletes the SR of Ca2+, was used as an indicator of Ca2+ content in the SR. The caffeine-induced [Ca2+]i transient was significantly reduced by U50,488H at 20 microM. This effect of U50,488H on caffeine-induced [Ca2+]i transient was significantly attenuated by 1 microM chelerythrine, indicating that the action of PKC involves mobilization of Ca2+ from the SR. When the increase in IP3 production in response to K-receptor stimulation with U50,488H in the ventricular myocyte was determined, the effect of U50,488H was the same in the presence and absence of staurosporine, suggesting that the effect of PKC activation subsequent to kappa-receptor stimulation does not involve IP3. The observations suggest that PKC may act directly at the SR. 4. In conclusion, the present study has provided evidence for the first time that PKC may be involved in the action of kappa-receptor stimulation on Ca2+ in the SR and cyclic AMP production, both of which play an essential role in Ca2+ homeostasis in the heart.published_or_final_versioKeywords
This publication has 28 references indexed in Scilit:
- Inhibition of [3H]‐U69593 binding and the cardiac effects of U50,488H by calcium channel blockers in the rat heartBritish Journal of Pharmacology, 1997
- High carbachol increases the electrically induced [Ca2+]i transient in the single isolated ventricular myocyte of ratsEuropean Journal of Pharmacology, 1997
- Lithium attenuates the effects of dynorphin A(1–13) on inositol 1,4,5-trisphosphate and intracellular CA2+ in rat ventricular myocytesLife Sciences, 1996
- Chronic U50,488H abolishes inositol 1,4,5-trisphosphate and intracellular Ca2+ elevations evoked by κ-opioid receptor in rat myocytesEuropean Journal of Pharmacology, 1996
- Signal Transduction in the Cardiac k-ReceptorNeurosignals, 1995
- Plasma Membrane Na+/H+ Exchanger Isoforms (NHE-1, -2, and -3) Are Differentially Responsive to Second Messenger Agonists of the Protein Kinase A and C PathwaysPublished by Elsevier ,1995
- A Comparative Study of Effects of Isoproterenol and Dihydroouabain on Calcium transients and Contraction in Cultured Rat Ventricular CellsJournal of Molecular and Cellular Cardiology, 1993
- Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase CScience, 1992
- Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assaysJournal of Molecular and Cellular Cardiology, 1991
- Opiate binding in rat hearts: Modulation of binding after hemorrhagic shockBiochemical and Biophysical Research Communications, 1985